Ashcroft F M, Kakei M, Gibson J S, Gray D W, Sutton R
University Laboratory of Physiology, John Radcliffe Hospital, Oxford, UK.
Diabetologia. 1989 Aug;32(8):591-8. doi: 10.1007/BF00285333.
The ATP- and sulphonylurea-sensitivity of the ATP-sensitive K-channel was measured in human pancreatic B cells. In inside-out patches, half-maximal inhibition of channel activity was produced by 10 mumol/l ATP (with 2 mM Mg2+) and ATP-inhibition was partially antagonised by ADP. A significantly lower sensitivity to ATP was found in whole-cell recordings. Tolbutamide inhibited whole-cell ATP-sensitive K-currents half-maximally at 18 mumol/l; the sensitivity to tolbutamide was somewhat less in the inside-out patch. Ca-activated K-channels were unaffected by tolbutamide (10 mmol/l). These results resemble those found for rodent B cells and suggest that sulphonylureas exert their therapeutic effects in Type 2 (non-insulin dependent) diabetes by inhibition of the ATP-sensitive K-channel.
在人胰岛β细胞中测量了ATP敏感性钾通道对ATP和磺脲类药物的敏感性。在膜内面向外的膜片上,10 μmol/L ATP(含2 mM Mg2+)可产生对通道活性的半数最大抑制,且ATP抑制作用可被ADP部分拮抗。在全细胞记录中发现对ATP的敏感性显著降低。甲苯磺丁脲在18 μmol/L时对全细胞ATP敏感性钾电流产生半数最大抑制;在膜内面向外的膜片中对甲苯磺丁脲的敏感性略低。钙激活钾通道不受10 mmol/L甲苯磺丁脲的影响。这些结果与在啮齿动物β细胞中发现的结果相似,提示磺脲类药物通过抑制ATP敏感性钾通道在2型(非胰岛素依赖型)糖尿病中发挥治疗作用。